These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
345 related articles for article (PubMed ID: 9222644)
21. Sodium-lithium countertransport activity in red blood cells of patients with IgA nephropathy. Boero R; Fabbri A; Degli Esposti E; Guarena C; Forneris G; Lucatello A; Sturani A; Quarello F; Fusaroli M; Piccoli G Am J Kidney Dis; 1993 May; 21(5 Suppl 2):61-5. PubMed ID: 8494021 [TBL] [Abstract][Full Text] [Related]
22. Erythrocyte cation transport systems in insulin-dependent diabetics: correlation with prorenin and albuminuria. Lijnen P; Fenyvesi A; Bex M; Bouillon R; Amery A J Hum Hypertens; 1994 Apr; 8(4):251-6. PubMed ID: 8021905 [TBL] [Abstract][Full Text] [Related]
23. Na/Li countertransport abnormalities in type 1 diabetes with and without nephropathy are familial. Mead PA; Wilkinson R; Thomas TH Diabetes Care; 2001 Mar; 24(3):527-32. PubMed ID: 11289480 [TBL] [Abstract][Full Text] [Related]
24. Exercise testing as a long-term predictor of the development of microalbuminuria in normoalbuminuric IDDM patients. O'Brien SF; Watts GF; Powrie JK; Shaw KM Diabetes Care; 1995 Dec; 18(12):1602-5. PubMed ID: 8722059 [TBL] [Abstract][Full Text] [Related]
25. Sodium-lithium countertransport in children with diabetes and their families. Houtman PN; Campbell FM; Shah V; Grant DB; Dunger DB; Dillon MJ Arch Dis Child; 1995 Feb; 72(2):133-6. PubMed ID: 7702375 [TBL] [Abstract][Full Text] [Related]
26. Increase in glomerular filtration rate in patients with insulin-dependent diabetes and elevated erythrocyte sodium-lithium countertransport. Carr S; Mbanya JC; Thomas T; Keavey P; Taylor R; Alberti KG; Wilkinson R N Engl J Med; 1990 Feb; 322(8):500-5. PubMed ID: 2300121 [TBL] [Abstract][Full Text] [Related]
27. Captopril reduces the risk of nephropathy in IDDM patients with microalbuminuria. The Microalbuminuria Captopril Study Group. Diabetologia; 1996 May; 39(5):587-93. PubMed ID: 8739919 [TBL] [Abstract][Full Text] [Related]
29. Increased sodium-lithium countertransport activity in red cells of IgA nephropathy patients. Boero R; Degli Esposti E; Fabbri A; Guarena C; Forneris G; Quarello F; Fusaroli M; Piccoli G Kidney Int; 1991 Dec; 40(6):1118-22. PubMed ID: 1762312 [TBL] [Abstract][Full Text] [Related]
30. Increased vascular endothelial growth factor serum concentrations may help to identify patients with onset of type 1 diabetes during childhood at risk for developing persistent microalbuminuria. Santilli F; Spagnoli A; Mohn A; Tumini S; Verrotti A; Cipollone F; Mezzetti A; Chiarelli F J Clin Endocrinol Metab; 2001 Aug; 86(8):3871-6. PubMed ID: 11502826 [TBL] [Abstract][Full Text] [Related]
31. Ethnic differences in red blood cell sodium/lithium countertransport and metabolic correlates of hypertension: an international collaborative study. Ragone E; Strazzullo P; Siani A; Iacone R; Russo L; Sacchi A; Cipriano P; Mancini M; Zhao G; Yuan XY; Li DY; Gong L Am J Hypertens; 1998 Aug; 11(8 Pt 1):935-41. PubMed ID: 9715785 [TBL] [Abstract][Full Text] [Related]
32. Elevated erythrocyte sodium-lithium counter-transport in hypertensive patients with non-insulin-dependent diabetes mellitus. Senda T; Serizawa N; Negishi K; Katayama S Diabetes Res Clin Pract; 1996 Mar; 31(1-3):37-44. PubMed ID: 8792100 [TBL] [Abstract][Full Text] [Related]
33. Erythrocyte cation transport systems and membrane lipids in insulin-dependent diabetes. Lijnen P; Fenyvesi A; Bex M; Bouillon R; Amery A Am J Hypertens; 1993 Sep; 6(9):763-70. PubMed ID: 8110430 [TBL] [Abstract][Full Text] [Related]
34. Effects of atorvastatin on red-blood cell Na(+)/Li(+) countertransport in hyperlipidemic patients with and without hypertension. Kosmidou MS; Hatzitolios AI; Adamidou A; Giannopoulos S; Raikos N; Parharidis G; Milionis HJ Am J Hypertens; 2008 Mar; 21(3):303-9. PubMed ID: 18202666 [TBL] [Abstract][Full Text] [Related]
35. Relevance of erythrocyte Na+/Li+ countertransport measurement in essential hypertension, hyperlipidaemia and diabetic nephropathy: a critical review. Van Norren K; Thien T; Berden JH; Elving LD; De Pont JJ Eur J Clin Invest; 1998 May; 28(5):339-52. PubMed ID: 9650006 [TBL] [Abstract][Full Text] [Related]
36. Predictors of the development of microalbuminuria in patients with Type 1 diabetes mellitus: a seven-year prospective study. The Microalbuminuria Collaborative Study Group. Diabet Med; 1999 Nov; 16(11):918-25. PubMed ID: 10588521 [TBL] [Abstract][Full Text] [Related]
37. [Activity of sodium-lithium cotransport in erythrocytes of patients with diabetes mellitus type I (IDDM) complicated by diabetic nephropathy in the renal failure stage]. Trelewicz P; Gumprecht J; Zukowska-Szczechowska E; Grzeszczak W; Moczulski D; Liszka M Pol Arch Med Wewn; 1997 Jun; 97(6):527-33. PubMed ID: 9441288 [TBL] [Abstract][Full Text] [Related]
38. The association between retinopathy, nephropathy, cardiovascular disease and long-term metabolic control in type 1 diabetes mellitus: a 5 year follow-up study of 442 adult patients in routine care. Agardh CD; Agardh E; Torffvit O Diabetes Res Clin Pract; 1997 Mar; 35(2-3):113-21. PubMed ID: 9179466 [TBL] [Abstract][Full Text] [Related]
39. Effects of lisinopril and nifedipine on the progression to overt albuminuria in IDDM patients with incipient nephropathy and normal blood pressure. The Italian Microalbuminuria Study Group in IDDM. Crepaldi G; Carta Q; Deferrari G; Mangili R; Navalesi R; Santeusanio F; Spalluto A; Vanasia A; Villa GM; Nosadini R Diabetes Care; 1998 Jan; 21(1):104-10. PubMed ID: 9538979 [TBL] [Abstract][Full Text] [Related]
40. Association between lipoprotein(a) and insulin-like growth factor I during puberty and the relationship to microalbuminuria in children and adolescents with IDDM. Rudberg S; Persson B Diabetes Care; 1995 Jul; 18(7):933-9. PubMed ID: 7555552 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]